| Overview |
| bs-2631R |
| IL-31RA/CRL3 Polyclonal Antibody |
| WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human, Mouse, Rat, Dog |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human IL-31RA |
| 401-500/764 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 133396 |
| Cell membrane |
| Interleukin-31 receptor subunit alpha; interleukin-31 receptor subunit alpha precursor; cytokine receptor NR10; mGLM-R; IL-31RA; zcytoR17; IL-31R-alpha; gp130-like receptor; IL-31R subunit alpha; novel cytokine receptor 10; IL-31 receptor subunit alpha; gp130-like monocyte receptor; interleukin 31RA; class I cytokine receptor; Il31ra; CRL3; CRL 3;GLM-R; Glmr; GPL; NR10; HGLM R; HGLMR; IL 31RA ; Interleukin 31 receptor A; MGC125346; PRO21384; Soluble type I cytokine receptor CRL3; IL31R_HUMAN. |
| IL31RA is related to gp130 (IL6ST; MIM 600694), the common receptor subunit for IL6 (MIM 147620)-type cytokines. Oncostatin M receptor (OSMR; MIM 601743) and IL31RA form the heterodimeric receptor through which IL31 (MIM 609509) signals. Expression of IL31RA and OSMR mRNA is induced in activated monocytes, and both mRNAs are constitutively expressed in epithelial cells (Dillon et al., 2004 [PubMed 15184896]).[supplied by OMIM]. |
| Application Dilution |
| WB |
1:300-5000 |
| ELISA |
1:500-1000 |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz